• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂可迅速下调培养的人卵巢癌细胞中其自身的内流转运体hCTR1。

Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells.

作者信息

Holzer Alison K, Katano Kuniyuki, Klomp Leo W J, Howell Stephen B

机构信息

Department of Medicine and the Rebecca and John Moores Cancer Center, University of California at San Diego, La Jolla, California 92093-0058, USA.

出版信息

Clin Cancer Res. 2004 Oct 1;10(19):6744-9. doi: 10.1158/1078-0432.CCR-04-0748.

DOI:10.1158/1078-0432.CCR-04-0748
PMID:15475465
Abstract

PURPOSE

Cisplatin (DDP)-resistant cells commonly exhibit reduced drug accumulation. Previous studies have shown that the major copper (Cu) influx transporter CTR1 controls the uptake of DDP in yeast and mammalian cells. The goal of this study was to examine the effect of Cu and DDP on the level and subcellular localization of hCTR1 protein in human ovarian carcinoma cells.

EXPERIMENTAL DESIGN

Cultured human ovarian carcinoma A2780 cells were exposed to DDP and Cu, and the effect on hCTR1 was determined using Western blot analysis and confocal digital deconvolution microscopy.

RESULTS

Loss of hCTR1 was triggered by DDP exposure in a concentration and time-dependent manner. Exposure to 0.5 micromol/L DDP for 5 minutes reduced hCTR1 levels and exposure to DDP concentrations > or =2 micromol/L caused almost complete disappearance. The loss of hCTR1 was observed within 1 minute of the start of exposure to 2 micromol/L DDP. Treatment of cells with 100 micromol/L Cu for 5 minutes produced a smaller effect. Pretreatment of cells with 2 micromol/L DDP for 5 minutes resulted in a 50% decrease in 64Cu uptake, demonstrating that the DDP-induced loss of hCTR1 detected by Western blot analysis and imaging was functionally significant.

CONCLUSIONS

DDP down-regulated the amount of its major influx transporter in cultured human ovarian carcinoma cells in a concentration- and time-dependent manner. The effect was observed at DDP concentrations within the range found in the plasma of patients being treated with DDP, and it occurred very quickly relative to the half-life of the drug.

摘要

目的

顺铂(DDP)耐药细胞通常表现出药物蓄积减少。既往研究表明,主要的铜(Cu)流入转运体CTR1控制酵母和哺乳动物细胞中DDP的摄取。本研究的目的是检测铜和DDP对人卵巢癌细胞中hCTR1蛋白水平和亚细胞定位的影响。

实验设计

将培养的人卵巢癌A2780细胞暴露于DDP和铜,使用蛋白质印迹分析和共聚焦数字去卷积显微镜确定对hCTR1的影响。

结果

DDP暴露以浓度和时间依赖性方式触发hCTR1缺失。暴露于0.5 μmol/L DDP 5分钟可降低hCTR1水平,暴露于≥2 μmol/L DDP浓度可导致几乎完全消失。在开始暴露于2 μmol/L DDP后1分钟内观察到hCTR1缺失。用100 μmol/L铜处理细胞5分钟产生较小影响。用2 μmol/L DDP预处理细胞5分钟导致64Cu摄取减少50%,表明蛋白质印迹分析和成像检测到的DDP诱导的hCTR1缺失具有功能意义。

结论

DDP以浓度和时间依赖性方式下调培养的人卵巢癌细胞中其主要流入转运体的量。在接受DDP治疗患者血浆中发现的DDP浓度范围内观察到该效应,并且相对于药物半衰期而言发生非常迅速。

相似文献

1
Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells.顺铂可迅速下调培养的人卵巢癌细胞中其自身的内流转运体hCTR1。
Clin Cancer Res. 2004 Oct 1;10(19):6744-9. doi: 10.1158/1078-0432.CCR-04-0748.
2
The internalization and degradation of human copper transporter 1 following cisplatin exposure.顺铂暴露后人铜转运蛋白1的内化与降解
Cancer Res. 2006 Nov 15;66(22):10944-52. doi: 10.1158/0008-5472.CAN-06-1710.
3
The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells.铜流入转运体人类铜转运蛋白1调节顺铂在人卵巢癌细胞中的摄取。
Mol Pharmacol. 2004 Oct;66(4):817-23. doi: 10.1124/mol.104.001198. Epub 2004 Jun 30.
4
Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.铜流入和流出转运蛋白对沙铂主要代谢产物JM118细胞药理学的调节作用。
Cancer Chemother Pharmacol. 2006 Jun;57(6):781-8. doi: 10.1007/s00280-005-0121-5. Epub 2005 Sep 17.
5
Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.主要铜流入转运体CTR1对顺铂、卡铂和奥沙利铂细胞内蓄积的作用。
Mol Pharmacol. 2006 Oct;70(4):1390-4. doi: 10.1124/mol.106.022624. Epub 2006 Jul 17.
6
Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.肺耐药相关蛋白对人卵巢癌细胞系顺铂耐药性的影响。
Oncol Rep. 2004 Dec;12(6):1365-70.
7
[Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].[凋亡相关基因及半胱天冬酶-3在顺铂耐药人卵巢癌细胞系中的作用]
Zhonghua Fu Chan Ke Za Zhi. 2003 Mar;38(3):158-61.
8
Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.X连锁凋亡抑制蛋白对人卵巢癌细胞化疗耐药中HtrA2/Omi的调控
Gynecol Oncol. 2005 May;97(2):413-21. doi: 10.1016/j.ygyno.2004.12.055.
9
Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells.顺铂与人卵巢癌细胞中铜转运蛋白ATP7B相互作用的共聚焦显微镜分析。
Clin Cancer Res. 2004 Jul 1;10(13):4578-88. doi: 10.1158/1078-0432.CCR-03-0689.
10
Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells.铜转运蛋白 1 与人卵巢癌细胞顺铂耐药的相关性。
J Inorg Biochem. 2012 Nov;116:1-10. doi: 10.1016/j.jinorgbio.2012.07.010. Epub 2012 Jul 26.

引用本文的文献

1
Targeting cuproptosis for cancer therapy: Focus on the anti-tumor immune system.针对铜死亡进行癌症治疗:聚焦抗肿瘤免疫系统。
Cancer Pathog Ther. 2024 Jul 27;3(3):226-243. doi: 10.1016/j.cpt.2024.07.005. eCollection 2025 May.
2
Quantifying Intracellular Platinum Accumulation Using Inductively Coupled Mass Spectrometry.采用电感耦合质谱法定量检测细胞内铂积累。
Curr Protoc. 2024 Sep;4(9):e70012. doi: 10.1002/cpz1.70012.
3
Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors.
卵巢癌化疗耐药性发展中的新参与者:卵巢癌干细胞、非编码RNA和核受体。
Cancer Drug Resist. 2024 Feb 28;7:6. doi: 10.20517/cdr.2023.152. eCollection 2024.
4
The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression.铜死亡相关基因和铜转运蛋白在癌症进展中的意义与前景
Front Oncol. 2023 Feb 28;13:1117164. doi: 10.3389/fonc.2023.1117164. eCollection 2023.
5
The copper transporter CTR1 and cisplatin accumulation at the single-cell level by LA-ICP-TOFMS.通过激光烧蚀电感耦合等离子体质谱法(LA-ICP-TOFMS)在单细胞水平上研究铜转运蛋白CTR1与顺铂的积累。
Front Mol Biosci. 2022 Nov 28;9:1055356. doi: 10.3389/fmolb.2022.1055356. eCollection 2022.
6
Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives.重新审视临床批准的铂类衍生物的抗癌毒性。
Int J Mol Sci. 2022 Dec 6;23(23):15410. doi: 10.3390/ijms232315410.
7
Mechanisms of chemotherapy resistance in ovarian cancer.卵巢癌化疗耐药的机制
Cancer Drug Resist. 2022 Apr 3;5(2):304-316. doi: 10.20517/cdr.2021.147. eCollection 2022.
8
Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer.成纤维细胞生长因子信号转导影响同源重组介导的 DNA 损伤修复,从而促进卵巢癌的耐药性。
Br J Cancer. 2022 Oct;127(7):1340-1351. doi: 10.1038/s41416-022-01899-z. Epub 2022 Jul 1.
9
Resistance to cis- and carboplatin initiated by epigenetic changes in ovarian cancer patients.卵巢癌患者表观遗传变化引发的顺铂和卡铂耐药性。
Cancer Drug Resist. 2019 Jun 19;2(2):271-296. doi: 10.20517/cdr.2019.010. eCollection 2019.
10
Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?化疗药物:与细胞死亡和耐药相关的信号通路。它们真的和肿瘤细胞一样聪明吗?
Transl Oncol. 2021 May;14(5):101056. doi: 10.1016/j.tranon.2021.101056. Epub 2021 Mar 6.